Diabetes Mellitus, Admission Glucose, and Outcomes After Stroke Thrombolysis: A Registry and Systematic Review
暂无分享,去创建一个
Pierre Amarenco | Julien Labreuche | G. Sirimarco | P. Amarenco | I. Klein | J. Desilles | M. Mazighi | B. Lapergue | J. Labreuche | E. Meseguer | J. González-Valcárcel | P. Lavallée | L. Cabrejo | C. Guidoux | Mikael Mazighi | Elena Meseguer | Lucie Cabrejo | Jean-Philippe Desilles | Bertrand Lapergue | Gaia Sirimarco | Jaime Gonzalez-Valcarcel | Philippa Lavallée | Celine Guidoux | Isabelle Klein | Philippa C. Lavallée | J. Désilles
[1] G. Pellegrini,et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat , 2001, Acta Diabetologica.
[2] Eric E. Smith,et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. , 2010, Archives of neurology.
[3] C. Molina,et al. Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An Independent Predictor of Poor Outcome After Systemic Thrombolysis , 2006, Stroke.
[4] K. Kario,et al. Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients: General Outcomes and Prognostic Factors From the SAMURAI Register , 2009, Stroke.
[5] H. Gerstein,et al. Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.
[6] D. Salat,et al. Ischemic Stroke Outcome and Early Infection: Its Deleterious Effect Seems to Operate Also among Tissue Plasminogen Activator-Treated Patients , 2011, European Neurology.
[7] P. Heuschmann,et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy , 2004 .
[8] F. Dubas. Pathologie des petites arteres et hémorragies cérébrales , 2003 .
[9] A. Alexandrov,et al. Pre–Tissue Plasminogen Activator Blood Pressure Levels and Risk of Symptomatic Intracerebral Hemorrhage , 2009, Stroke.
[10] R. Swanson,et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke , 2008, Annals of neurology.
[11] R. Bloch,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[12] B. Hopkinson,et al. Intra-arterial thrombolysis using recombinant tissue plasminogen activator (r-TPA): the optimal agent, at the optimal dose? , 1989, European journal of vascular surgery.
[13] J. Serfaty,et al. Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study , 2009, The Lancet Neurology.
[14] J. Brøgger,et al. The effect of physiologic derangement in patients with stroke treated with thrombolysis. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[15] M. Chen,et al. Intra-arterial Thrombolysis or Stent Placement During Endovascular Treatment for Acute Ischemic Stroke Leads to the Highest Recanalization Rate: Results of a Multicenter Retrospective Study , 2011, Neurosurgery.
[16] P. Heuschmann,et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. , 2004, JAMA.
[17] J. Marler,et al. Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.
[18] E. López‐Cancio,et al. Influence of antiplatelet pre‐treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis , 2010, European journal of neurology.
[19] J. Schulte‐Mönting,et al. Hyperglycemia in Patients with Focal Cerebral Ischemia after Intravenous Thrombolysis: Influence on Clinical Outcome and Infarct Size , 2002, Cerebrovascular Diseases.
[20] D. Tanné,et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke , 2001, Neurology.
[21] Á. Chamorro,et al. Uric Acid Levels Are Relevant in Patients With Stroke Treated With Thrombolysis , 2011, Stroke.
[22] R. Delgado-Mederos,et al. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case–control study and a meta-analysis , 2011, Journal of Neurology.
[23] F. Dubas. [Small vessel pathology and cerebral hemorrhage]. , 2003, Journal of neuroradiology. Journal de neuroradiologie.
[24] R. Silbergleit,et al. Lack of Association between Hyperglycaemia at Arrival and Clinical Outcomes in Acute Stroke Patients Treated with Tissue Plasminogen Activator , 2010, International journal of stroke : official journal of the International Stroke Society.
[25] L. Defebvre,et al. Intravenous Thrombolysis for Acute Cerebral Ischaemia: Comparison of Outcomes between Patients Treated at Working versus Nonworking Hours , 2010, Cerebrovascular Diseases.
[26] V. Hachinski,et al. Predictors of major neurologic improvement after thrombolysis in acute stroke , 2005, Neurology.
[27] J. Arenillas,et al. The Metabolic Syndrome Is Associated With a Higher Resistance to Intravenous Thrombolysis for Acute Ischemic Stroke in Women Than in Men , 2009, Stroke.
[28] Sumit R. Majumdar,et al. Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis , 2008, Diabetes Care.
[29] H. Chandalia,et al. STRESS HYPERGLYCAEMIA , 1984, The Lancet.
[30] M. Reichhart,et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis , 2005, Neurology.
[31] B. T. Hawkins,et al. Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases , 2006, Diabetologia.
[32] D. Singer,et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. , 2000, JAMA.
[33] J. Grotta,et al. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. , 2009, Stroke.
[34] Partial Complementation of Sinorhizobium meliloti bacA Mutant Phenotypes by the Mycobacterium tuberculosis BacA Protein , 2012, Journal of bacteriology.
[35] J. Provencio. Multimodal Reperfusion Therapy for Acute Ischemic Stroke: Factors Predicting Vessel Recanalization , 2008 .
[36] P. Amarenco,et al. Glucose Level and Brain Infarction: A Prospective Case-Control Study and Prospective Study , 2009, International journal of stroke : official journal of the International Stroke Society.
[37] M. Kaste,et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). , 2010, Archives of Neurology.
[38] G. Moretto,et al. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study , 2011, Journal of the Neurological Sciences.
[39] Yong Y. He,et al. Effect of plasma glucose on infarct size in focal cerebral ischemia‐reperfusion , 1991, Neurology.
[40] Carlos A Molina,et al. Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis: Risk Stratification in Relation to Time to Reperfusion , 2004, Stroke.
[41] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[42] A. Yoo,et al. Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. , 2011, Journal of neurosurgery.
[43] D. Hadley,et al. Randomized, controlled trial of insulin for acute poststroke hyperglycemia , 2010, Annals of neurology.
[44] S. Muengtaweepongsa,et al. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis , 2011, Journal of the Neurological Sciences.
[45] Gerhard Schroth,et al. Endovascular Therapy of 623 Patients With Anterior Circulation Stroke , 2012, Stroke.
[46] J. Serfaty,et al. Blood–brain barrier disruption is associated with increased mortality after endovascular therapy , 2013, Neurology.
[47] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[48] Werner Hacke,et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study , 2006, The Lancet Neurology.
[49] R. Keep,et al. Effect of Sustained-Mild and Transient-Severe Hyperglycemia on Ischemia-Induced Blood–Brain Barrier Opening , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] P. Sandercock,et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) , 2007, The Lancet Neurology.
[51] R. Higashida,et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke , 2001, Neurology.
[52] J. De Keyser,et al. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. , 2007, Brain : a journal of neurology.
[53] J. Arenillas,et al. Acute Hyperglycemia State Is Associated With Lower tPA-Induced Recanalization Rates in Stroke Patients , 2005, Stroke.
[54] J. Arenillas,et al. Body temperature and response to thrombolytic therapy in acute ischaemic stroke , 2008, European journal of neurology.
[55] F. Aichner,et al. Prognostic value of admission C-reactive protein in stroke patients undergoing IV thrombolysis , 2008, Journal of Neurology.
[56] Andrew M Southerland,et al. Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial , 2012, Annals of the New York Academy of Sciences.
[57] Andrew M. Demchuk,et al. Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey , 2002, Circulation.
[58] S. Chinn. A simple method for converting an odds ratio to effect size for use in meta-analysis. , 2000, Statistics in medicine.
[59] W. Hacke,et al. Frequency of Increased Blood Pressure Levels During Systemic Thrombolysis and Risk of Intracerebral Hemorrhage , 2011, Stroke.
[60] A. Demchuk,et al. Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry , 2007, Stroke.
[61] G. Christoforidis,et al. Predictors of Hemorrhage Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke: The Role of Pial Collateral Formation , 2008, American Journal of Neuroradiology.
[62] C. Homko,et al. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. , 2006, Diabetes.
[63] J. Sunshine,et al. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[64] K. Kario,et al. [Effects of statin use on intracranial hemorrhage and clinical outcome after intravenous rt-PA for acute ischemic stroke: SAMURAI rt-PA registry]. , 2010, Rinsho shinkeigaku = Clinical neurology.
[65] P. Chan,et al. Influence of Hyperglycemia on Oxidative Stress and Matrix Metalloproteinase-9 Activation After Focal Cerebral Ischemia/Reperfusion in Rats: Relation to Blood-Brain Barrier Dysfunction , 2007, Stroke.
[66] S. Davis,et al. Rapid Neurological Recovery after Intravenous Tissue Plasminogen Activator in Stroke: Prognostic Factors and Outcome , 2010, Cerebrovascular Diseases.
[67] Scott E Kasner,et al. Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials , 2009, Stroke.
[68] L. Wechsler,et al. Factors Predicting Hemorrhagic Complications after Multimodal Reperfusion Therapy for Acute Ischemic Stroke , 2007, American Journal of Neuroradiology.
[69] J. Broderick,et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial , 2002, Neurology.
[70] F. Berthier,et al. [Intravenous thrombolysis with rt-PA in stroke: experience of the Nice stroke unit]. , 2009, Revue neurologique.
[71] J H Devries,et al. Hyperglycemia: a prothrombotic factor? , 2010, Journal of thrombosis and haemostasis : JTH.
[72] N. Salamon,et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis , 2007, Neurology.
[73] A. Demchuk,et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. , 1999, Stroke.
[74] W. Poewe,et al. Recanalization after thrombolysis in stroke patients , 2007, Neurology.
[75] J. Serfaty,et al. Outcomes of Mechanical Endovascular Therapy for Acute Ischemic Stroke: A Clinical Registry Study and Systematic Review , 2011, Stroke.
[76] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[77] J. French,et al. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke , 1999, The Lancet.
[78] W. Koroshetz,et al. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke , 2007, Neurology.
[79] G. Luijckx,et al. Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke , 2007, Journal of the Neurological Sciences.
[80] Dong Joon Kim,et al. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients , 2009, Journal of the Neurological Sciences.
[81] D. Wagner,et al. Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke , 2003, Stroke.
[82] Very early neurologic improvement after intravenous thrombolysis. , 2010, Archives of neurology.
[83] P. Adeleine,et al. Early Fibrinogen Degradation Coagulopathy Is Predictive of Parenchymal Hematomas in Cerebral rt-PA Thrombolysis: A Study of 157 Cases , 2004, Stroke.
[84] Mark W Parsons,et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study , 2002, Annals of neurology.
[85] Wade S. Smith,et al. Predictors of Good Clinical Outcomes, Mortality, and Successful Revascularization in Patients With Acute Ischemic Stroke Undergoing Thrombectomy: Pooled Analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials , 2009, Stroke.
[86] J. Goldstein,et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. , 2010, Archives of neurology.
[87] J. Martí-Fàbregas,et al. Influence of Antiplatelet Pre-Treatment on the Risk of Symptomatic Intracranial Haemorrhage after Intravenous Thrombolysis , 2008, Cerebrovascular Diseases.